MYND Life Sciences
Business Services Ā· Canada Ā· 11-50 Employees
View Company Info for Free
Overview
Headquarters
719 Finns Rd, Kelowna, British Columbia,...Phone Number
(403) 559-6779Website
www.myndsciences.comRevenue
<$5 MillionStock Symbol
MYNDFIndustry
About MYND Life Sciences
MYND Life Sciences Org Chart
Is MYND Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MYND Life Sciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at MYND Life Sciences
Click to see if MYND Life Sciences had a recent Job posting/layoffs
Earning: See what the market has to say on MYND Life Sciences recently announced quarterly report
Product Launch: Get notified when MYND Life Sciences launches new products
Website visits: Recent activity has been detected on your website
Check out if MYND Life Sciences is spiking on competitors!
Check if MYND Life Sciences has recently received funding, and reach out quickly before it becomes old news!
MYND Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at MYND Life Sciences
Find 2 more new buyers
Compare Similar Companies to MYND Life Sciences
Compare insights from companies similar to MYND Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MYND Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
MYND Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about MYND Life Sciences.
MYND Life Sciences financials insights
Gather financial insights about MYND Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Grant
$46K
MYND Life Sciences Tech Stack
A closer look at the technologies used by MYND Life Sciences
Most Recent Scoops
MYND Life Sciences News & Media
MYND Life Sciences Inc. Announces Non-Binding MOU with German Based Oxygen Handel and Provides Default Status Report
[DATELINE]MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological diseases, today announced it has entered into a non-binding memorandum of understanding ("MOU") with Oxygen Handel GmbH (O2 Handel).Oxygen Handel is a privately held science-based, research-driven pharmaceutical company consisting of carefully selected, highly qualified teams of...MYND Diagnostics Inc. Announces Participation in Approved Monash University (Australia) Government Funded $3 Million Clinical Trial
Clinical validation of MYND Diagnostics' proprietary biomarkers in evaluating the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression VANCOUVER, BC, Feb. 8, 2022 /PRNewswire/ - MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND)...MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia
MYND's Second CRA focuses on Novel Therapies for Neurological Diseases of the Brain VANCOUVER, BC, Jan. 12, 2022 /PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) a biopharmaceutical research and development company creating innovative precision...MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer's Disease and other Dementias
Acquisition will strengthen MYND's psilocybin-assisted medicinal and diagnostics capabilities, adding novel psychedelics for the treatment of dementia, including Alzheimer's disease. VANCOUVER, BC, Dec. 17, 2021 /PRNewswire/ - Further to news release of October 27, 2021, MYND Life...
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MYND Life Sciences
MYND Life Sciences, headquartered in Canada, is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel psilocybin drug development, diagnostics and vaccines. The Company is advancing pharmaceuticals through rigorous science and clinical trials, while diligently patenting and safeguarding its intellectual p... Read More